Henrique Tada of ALANAC, the association that brings together Brazil's domestic pharma companies, comments on the evolution of the Brazilian generics,…

In a wide-ranging interview, AbbVie’s Flavio Devoto outlines some of the key access challenges and opportunities in the diverse Latin American…

The latest from Brazilian Pharma, including the controversial proposal to transform Brazil's regulatory agency, ANVISA; Ease Labs's canabidiol…

Guilherme Marques, president of Siemens Healthineers LatAm, discusses the health tech giant's regional strategy, covering how the firm rides out the…

In 2019 the pharma industry financed some 700 clinical studies in Latin America with investments of more than USD one billion and according to…

A breakdown of the investments made by the pharmaceutical industry in clinical studies across the Latin American region. According to the US National…

As selected by the Generics & Biosimilars Initiative (GABI), these are the top ten pharma companies ranked by turnover in Argentina, Brazil,…

Renata Mihich, a 25-year DHL veteran, recently took on a new role as Head of LatAm for Italian healthcare logistics specialist BOMI GROUP. At a moment…

Rolf Hoenger describes how Roche is driving access and awareness for innovative medicines in Latin America and weighs in on a number of important…

After a successful international career, Andre Vivan da Silva recently returned to his native Brazil to become GSK’s country manager. He explains…

Although Brazil is one of the world’s top pharma markets, with the highest market value in Latin America, and has made major strides towards…

Two Big Pharma SVPs with responsibility for the entirety of Latin America weigh in on the management challenges inherent in LatAm and what they look…